Novel therapies for rheumatoid arthritis. - Wikidata - awgldk - TriplyDB

Novel therapies for rheumatoid arthritis.

Novel therapies for rheumatoid arthritis.

http://www.wikidata.org/entity/Q36623081

about

Induction of apoptosis of human primary osteoclasts treated with extracts from the medicinal plant Emblica officinalis Therapeutic effect of a poly(ADP-ribose) polymerase-1 inhibitor on experimental arthritis by downregulating inflammation and Th1 response.Increased expression of beta-arrestin 1 and 2 in murine models of rheumatoid arthritis: isoform specific regulation of inflammation Osteoarticular Expression of Musashi-1 in an Experimental Model of Arthritis Stress, heat shock proteins, and autoimmunity: how immune responses to heat shock proteins are to be used for the control of chronic inflammatory diseases.Manipulating B cell homeostasis: a key component in the advancement of targeted strategies Altered influenza virus haemagglutinin (HA)-derived peptide is potent therapy for CIA by inducing Th1 to Th2 shift.Targeted drugs in combination with radiotherapy for the treatment of solid tumors: current state and future developments.Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 responses.An altered peptide ligand corresponding to a novel epitope from heat-shock protein 60 induces regulatory T cells and suppresses pathogenic response in an animal model of adjuvant-induced arthritis

P2860

Q21254649-00984FD4-2B05-4E64-BA41-4724A3CA9A87 Q33304428-99F58438-078F-4C66-B7D9-56BA1E0D9147 Q35490940-54D9B697-F5FC-4312-8089-1108D22AFD67 Q35612503-2B18F687-14AC-4F7E-8D9A-1DD0C11A91DD Q36856283-86826624-6F60-4A38-9F61-E05FB895774F Q37177128-2242AF0C-2E81-4FA7-BE6B-1ADF9737F871 Q37728230-797B44EE-EDF0-4F55-B572-ED13EADA90EB Q38155932-33CFE369-D593-4660-8454-A065EDB358F5 Q42152081-33039231-F8BC-4005-8312-E145FAD64247 Q58326924-B71D82AF-42C2-4A07-89B9-A9483CC978CA

P2860

Novel therapies for rheumatoid arthritis.

http://www.wikidata.org/entity/Q36623081

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Novel therapies for rheumatoid arthritis.

@ast

Novel therapies for rheumatoid arthritis.

@en

type

label

Novel therapies for rheumatoid arthritis.

@ast

Novel therapies for rheumatoid arthritis.

@en

prefLabel

Novel therapies for rheumatoid arthritis.

@ast

Novel therapies for rheumatoid arthritis.

@en

P1433

Q36623081-E51E981C-520D-4684-A6E5-265B620B01E9

P1476

Q36623081-3469CB54-0D8D-4093-88D2-D687BC097353

P2093

Q36623081-02E75247-364D-4628-B399-8E03F2F47559

Q36623081-8A982061-374A-4881-AA13-6815CA2571AB

P2860

Q36623081-104F2205-C5D0-4260-BC8A-290CBE9DE5B7

Q36623081-12607C3B-003D-4974-8B6A-F1F0BFA41F17

Q36623081-13DD68D5-6E66-4173-939A-9F8D89B93212

Q36623081-1D9115A7-E7B2-4111-B8A3-CCE992056B4D

Q36623081-1EC9BDA6-6E4A-437C-8AED-4D21FE6186F5

Q36623081-1F03CFD4-1D34-4912-A823-D54E5FA2DDFE

Q36623081-1FF07908-28C3-449E-A56F-B27A2AE0CEBB

Q36623081-21E31FEA-F467-4F46-A067-34FBB2C8589C

Q36623081-23E06FD4-89AC-4D69-B213-9A968EF273C5

Q36623081-23F12473-2BE0-4D63-AB6C-EC1291543101

P304

Q36623081-01D926C0-E49C-41C1-A642-755F31746295

P31

Q36623081-5E2AE51E-45A3-471B-ADEB-9FB8FAE91135

P356

Q36623081-B9733A67-0AB1-4D07-A85C-388D7DA8226B

P407

Q36623081-38F334FD-7A10-4B32-87FE-096C0B42ED36

P433

Q36623081-4C0965E9-2DA9-46B4-A541-3FC5CDD4910B

P478

Q36623081-B4E670FA-3C31-43C7-978C-F094AB1C418A

P577

Q36623081-0D3A4320-6150-46E2-915B-3C3B648A0534

P5875

Q36623081-478CC346-6FF9-4538-8430-7BDF19339182

P698

Q36623081-76594516-8889-4C30-93F3-EC61E7F29F88

P356

13543784.15.11.1427

P1433

Expert Opinion on Investigational Drugs

P1476

Novel therapies for rheumatoid arthritis.

@en

P2093

Adriana H Tremoulet

http://www.w3.org/2001/XMLSchema#string

Salvatore Albani

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis

Safety of extended treatment with anakinra in patients with rheumatoid arthritis

CTLA-4 ligation blocks CD28-dependent T cell activation

Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen

Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolong

Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin.

Cytokine traps: multi-component, high-affinity blockers of cytokine action

Chemokine receptor expression in rat adjuvant-induced arthritis

Chemokine receptor expression and in vivo signaling pathways in the joints of rats with adjuvant-induced arthritis

Human anti-human IL-18 antibody recognizing the IL-18-binding site 3 with IL-18 signaling blocking activity.

P304

1427-1441

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.15.11.1427

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2006-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6755749

http://www.w3.org/2001/XMLSchema#string

P698

17040201

http://www.w3.org/2001/XMLSchema#string